Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Gulistan Bahat, Cihan Kilic, Yildiray Topcu, Kubra Aydin & Mehmet Akif Karan. (2020) Fat percentage cutoff values to define obesity and prevalence of sarcopenic obesity in community-dwelling older adults in Turkey. The Aging Male 23:5, pages 477-482.
Read now
Read now
Nur-Vaizura Mohamad, Soelaiman Ima-Nirwana & Kok-Yong Chin. (2020) The effects of gonadotropin-releasing hormone agonist (buserelin) and orchidectomy on bone turnover markers and histomorphometry in rats. The Aging Male 23:5, pages 327-334.
Read now
Read now
Marta Martín-Fernández, Francisco-Miguel Garzón-Márquez, Manuel Díaz-Curiel, Iván Prieto-Potin, Luis Alvarez-Galovich, David Guede, Jose Ramón Caeiro-Rey & Concepción De la Piedra. (2020) Comparative study of the effects of osteoprotegerin and testosterone on bone quality in male orchidectomised rats. The Aging Male 23:3, pages 189-201.
Read now
Read now
Paolo Sgrò, Massimiliano Sansone, Andrea Sansone, Stefania Sabatini, Paolo Borrione, Francesco Romanelli & Luigi Di Luigi. (2019) Physical exercise, nutrition and hormones: three pillars to fight sarcopenia. The Aging Male 22:2, pages 75-88.
Read now
Read now
Tom E. Nightingale, Pamela Moore, Joshua Harman, Refka Khalil, Ranjodh S. Gill, Teodoro Castillo, Robert A. Adler & Ashraf S. Gorgey. (2018) Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review. The Journal of Spinal Cord Medicine 41:6, pages 624-636.
Read now
Read now
Kazuyoshi Shigehara, Hiroyuki Konaka, Eitetsu Koh, Kazufumi Nakashima, Masashi Iijima, Takahiro Nohara, Koji Izumi, Yasuhide Kitagawa, Yoshifumi Kadono, Kazuhiro Sugimoto, Teruaki Iwamoto, Atsushi Mizokami & Mikio Namiki. (2017) Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study). The Aging Male 20:3, pages 139-145.
Read now
Read now
Giovanni Corona, Elisa Maseroli, Giulia Rastrelli, Andrea M Isidori, Alessandra Sforza, Edoardo Mannucci & Mario Maggi. (2014) Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opinion on Drug Safety 13:10, pages 1327-1351.
Read now
Read now
Prasanth Surampudi, Ronald S Swerdloff & Christina Wang. (2014) An update on male hypogonadism therapy. Expert Opinion on Pharmacotherapy 15:9, pages 1247-1264.
Read now
Read now
Pierre M. G. Bouloux, Jean-Jacques Legros, Jolanda M. H. Elbers, T. B. Paul Geurts, Marion J. G. H. Kaspers, Alan G. Meehan & Eric J. H. Meuleman. (2013) Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study. The Aging Male 16:2, pages 38-47.
Read now
Read now
Articles from other publishers (34)
Karel David, Nick Narinx, Leen Antonio, Pieter Evenepoel, Frank Claessens, Brigitte Decallonne & Dirk Vanderschueren. (2022) Bone health in ageing men. Reviews in Endocrine and Metabolic Disorders 23:6, pages 1173-1208.
Crossref
Crossref
Biagio Barone, Luigi Napolitano, Marco Abate, Luigi Cirillo, Pasquale Reccia, Francesco Passaro, Carmine Turco, Simone Morra, Francesco Mastrangelo, Antonio Scarpato, Ugo Amicuzi, Vincenzo Morgera, Lorenzo Romano, Francesco Paolo Calace, Savio Domenico Pandolfo, Luigi De Luca, Achille Aveta, Enrico Sicignano, Massimiliano Trivellato, Gianluca Spena, Carlo D’Alterio, Giovanni Maria Fusco, Raffaele Vitale, Davide Arcaniolo & Felice Crocetto. (2022) The Role of Testosterone in the Elderly: What Do We Know?. International Journal of Molecular Sciences 23:7, pages 3535.
Crossref
Crossref
Béatrice Bouvard, Karine Briot, Erick Legrand, Hubert Blain, Véronique Breuil, Roland Chapurlat, Marc Duquenne, Pascal Guggenbuhl, Eric Lespessailles, Thierry Thomas & Bernard Cortet. (2021) Recommandations françaises de la prise en charge et du traitement de l’ostéoporose masculine. Revue du Rhumatisme 88:3, pages 173-182.
Crossref
Crossref
Zhichao Zhang, Deying Kang & Hongjun Li. (2020) The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis. BMC Endocrine Disorders 20:1.
Crossref
Crossref
Vincenzo Rochira. (2020) Late‐onset Hypogonadism: Bone health. Andrology 8:6, pages 1539-1550.
Crossref
Crossref
Jeffrey D. Zajac, Ego Seeman, Nicholas Russell, Sabashini K. Ramchand, Ingrid Bretherton, Mathis Grossmann & Rachel A. Davey. 2020. Encyclopedia of Bone Biology. Encyclopedia of Bone Biology
533
550
.
Antonio Aversa & Alessandro Ilacqua. 2020. Male Osteoporosis. Male Osteoporosis
177
182
.
Jia-Feng Chen, Pei-Wen Lin, Yi-Ru Tsai, Yi-Chien Yang & Hong-Yo Kang. (2019) Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy. Cells 8:11, pages 1318.
Crossref
Crossref
Abraham Morgentaler, Abdulmaged Traish, Geoffrey Hackett, T. Hugh Jones & Ranjith Ramasamy. (2019) Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine. Sexual Medicine Reviews 7:4, pages 636-649.
Crossref
Crossref
Omar Seyam, Jason Gandhi, Gunjan Joshi, Noel L. Smith & Sardar Ali Khan. (2019) Obesity’s role in secondary male hypogonadism: a review of pathophysiology and management issues. SN Comprehensive Clinical Medicine 1:6, pages 408-418.
Crossref
Crossref
Bu B. Yeap. 2019. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases
729
738
.
Bu B Yeap, Stephanie T Page & Mathis Grossmann. (2018) Testosterone treatment in older men: clinical implications and unresolved questions from the Testosterone Trials. The Lancet Diabetes & Endocrinology 6:8, pages 659-672.
Crossref
Crossref
Giovanni Corona, Giulia Rastrelli, Giuseppe Di Pasquale, Alessandra Sforza, Edoardo Mannucci & Mario Maggi. (2018) Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies. The Journal of Sexual Medicine 15:6, pages 820-838.
Crossref
Crossref
Marco Antônio R. Loures, Cristiano Augusto F. Zerbini, Jaime S. Danowski, Rosa Maria R. Pereira, Caio Moreira, Ana Patrícia de Paula, Charlles Heldan M. Castro, Vera Lúcia Szejnfeld, Laura Maria C. Mendonça, Sebastião C. Radominiski, Mailze C. Bezerra, Ricardo Simões & Wanderley M. Bernardo. (2017) Guidelines of the Brazilian Society of Rheumatology for the diagnosis and treatment of osteoporosis in men. Revista Brasileira de Reumatologia (English Edition) 57, pages 497-514.
Crossref
Crossref
Marco Antônio R. Loures, Cristiano Augusto F. Zerbini, Jaime S. Danowski, Rosa Maria R. Pereira, Caio Moreira, Ana Patrícia de Paula, Charlles Heldan M. Castro, Vera Lúcia Szejnfeld, Laura Maria C. Mendonça, Sebastião C. Radominiski, Mailze C. Bezerra, Ricardo Simões & Wanderley M. Bernardo. (2017) Diretrizes da Sociedade Brasileira de Reumatologia para diagnóstico e tratamento da osteoporose em homens. Revista Brasileira de Reumatologia 57, pages 497-514.
Crossref
Crossref
Abdulmaged M. Traish. 2017. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
473
526
.
Toshimi Tando, Yuiko Sato, Kana Miyamoto, Mayu Morita, Tami Kobayashi, Atsushi Funayama, Arihiko Kanaji, Wu Hao, Ryuichi Watanabe, Takatsugu Oike, Masaya Nakamura, Morio Matsumoto, Yoshiaki Toyama & Takeshi Miyamoto. (2016) Hif1α is required for osteoclast activation and bone loss in male osteoporosis. Biochemical and Biophysical Research Communications 470:2, pages 391-396.
Crossref
Crossref
Christopher D. Gaffney, Matthew J. Pagano, Adriana P. Kuker, Doron S. Stember & Peter J. Stahl. (2015) Osteoporosis and Low Bone Mineral Density in Men with Testosterone Deficiency Syndrome. Sexual Medicine Reviews 3:4, pages 298-315.
Crossref
Crossref
Dirk VanderschuerenMichaël R. LaurentFrank ClaessensEvelien GielenMarie K. Lagerquist, Liesbeth Vandenput, Anna E. Börjesson & Claes Ohlsson. (2014) Sex Steroid Actions in Male Bone. Endocrine Reviews 35:6, pages 906-960.
Crossref
Crossref
Se Hwa Kim. (2014) Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism. Endocrinology and Metabolism 29:1, pages 30.
Crossref
Crossref
Jennifer S. Walsh & Richard Eastell. (2013) Osteoporosis in men. Nature Reviews Endocrinology 9:11, pages 637-645.
Crossref
Crossref
Emmanuel Hopp?B?atrice Bouvard, Mathieu Royer, Daniel Chappard, Maurice Audran & ?rick Legrand. (2013) Faut-il donner des androg?nes aux hommes ost?oporotiques??. Revue du Rhumatisme 80:5, pages 446-452.
Crossref
Crossref
Emmanuel Hopp?B?atrice Bouvard, Mathieu Royer, Daniel Chappard, Maurice Audran & Erick Legrand. (2013) Is androgen therapy indicated in men with osteoporosis?. Joint Bone Spine 80:5, pages 459-465.
Crossref
Crossref
Mary Beth O’Connell & Sheryl Vondracek. (2013) Preventing and treating osteoporosis in men. Pharmacy Today 19:7, pages 60-71.
Crossref
Crossref
Ronald S. Swerdloff & Christina C. L. Wang. 2012. Testosterone. Testosterone
408
420
.
Nelson B. Watts, Robert A. Adler, John P. Bilezikian, Matthew T. Drake, Richard Eastell, Eric S. Orwoll & Joel S. Finkelstein. (2012) Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 97:6, pages 1802-1822.
Crossref
Crossref
Prasanth N. Surampudi, Christina Wang & Ronald Swerdloff. (2012) Hypogonadism in the Aging Male Diagnosis, Potential Benefits, and Risks of Testosterone Replacement Therapy. International Journal of Endocrinology 2012, pages 1-20.
Crossref
Crossref
Farid Saad, Antonio Aversa, Andrea M Isidori, Livia Zafalon, Michael Zitzmann & Louis Gooren. (2011) Onset of effects of testosterone treatment and time span until maximum effects are achieved. European Journal of Endocrinology 165:5, pages 675-685.
Crossref
Crossref
Andrew C. Martin. (2011) Osteoporosis in Men. Journal of Pharmacy Practice 24:3, pages 307-315.
Crossref
Crossref
Brian J. Gates & Shyamal Das. (2011) Management of osteoporosis in elderly men. Maturitas 69:2, pages 113-119.
Crossref
Crossref
Glenn R. Cunningham & Shivani M. Toma. (2011) Why Is Androgen Replacement in Males Controversial?. The Journal of Clinical Endocrinology & Metabolism 96:1, pages 38-52.
Crossref
Crossref
Kishore M. Lakshman, Shalender Bhasin & Andre B. Araujo. 2010. Osteoporosis in Men. Osteoporosis in Men
691
712
.
Risto Huupponen, Ilpo Huhtaniemi & Aapo Lehtonen. (2009) Testosterone: clinical relevance in ageing men. Reviews in Clinical Gerontology 19:4, pages 249-261.
Crossref
Crossref
Ramachandran Ilangovan, Sivanandane Sittadjody, Muthusamy Balaganesh, Ramadoss Sivakumar, Bhaskaran Ravi Sankar, Karundevi Balasubramanian, Subramanian Srinivasan, Chinappa Subramanian, David M. Thompson, Lurdes Queimado & Narasimhan Srinivasan. (2009) Dihydrotestosterone is a determinant of calcaneal bone mineral density in men. The Journal of Steroid Biochemistry and Molecular Biology 117:4-5, pages 132-138.
Crossref
Crossref